SCHEMBL4053403

SCHEMBL4053403

Nc1cc(C(F)(F)F)nn1-c1ccc(C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.60
PTGS1 P23219 3/20 0.52
KLKB1 P03952 2/20 0.47
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
NCOR2 Q9Y618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1408409 0.85 GRN (0.55) PTGS2PTGS1NPC1TP53MAPT
SCHEMBL31420366 0.84 PTGS2 (0.58) PTGS2PTGS1KLKB1MAPTHDAC3
SCHEMBL22143177 0.83 PTGS1 (0.56) PTGS2PTGS1MAPTSMN1; SMN2HDAC3
SCHEMBL25249559 0.82 PTGS2 (0.57) PTGS2PTGS1KLKB1MAPTHDAC3
SCHEMBL1012734 0.81 PTGS1 (0.63) PTGS2PTGS1KLKB1NPC1TP53
SCHEMBL2083765 0.80 ALDH1A1 (0.53) PTGS1MAPTSMN1; SMN2HDAC3HDAC4
SCHEMBL1013645 0.80 PTGS2 (0.55) PTGS2PTGS1NPC1RAB9ASMN1; SMN2
SCHEMBL4247328 0.79 PTGS2 (0.74) PTGS2PTGS1TP53MAPTSMN1; SMN2
SCHEMBL31255079 0.79 PTGS2 (0.54) PTGS2PTGS1KLKB1MAPTSMN1; SMN2
SCHEMBL1013244 0.78 CYP2C9 (0.57) PTGS2PTGS1NPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836173-A4 ANTI-INFLAMMATORY MEDICAMENTS DECIPHERA PHARMACEUTICALS LLC (US) 2009-07-08 EP disclosed
EP-1836173-A2 ANTI-INFLAMMATORY MEDICAMENTS Deciphera Pharmaceuticals, LLC (US) 2007-09-26 EP disclosed
WO-2006081034-A2 ANTI-INFLAMMATORY MEDICAMENTS DECIPHERA PHARMACEUTICALS, LLC (US) 2006-08-03 WO disclosed